ArticleJournal of medical devices2025
MBaFus: A Virtual Lab of Microbubble-Augmented Focused Ultrasound for Noninvasive Tumor Ablation Based on Two-Way Coupled Euler-Lagrange Modeling.
Article in Journal of medical devices, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Focused ultrasound (FUS), especially when augmented by microbubbles (MBs), shows the potential for noninvasive ablation of deep-seated tumors, but its clinical adoption is hindered due to its dependency on multiple controllable parameters of FUS and MBs. To accelerate the clinical transition of this noninvasive and target therapy, a virtual lab featuring a two-way coupled Euler-Lagrange computation platform, capable of capturing physics down to individual MBs thus their nonlinear interactions, has been developed to accurately predict the acoustic and thermal fields for microbubble-augmented FUS (MBaFus), and subsequently the resultant temperature rise at the treatment spots. This technical brief concisely summarizes the main features of its numerical algorithms for prediction and high-performance computing schemes for speedup, as well as its preliminary validation against in vitro experiments. Recent progress on further evaluating the numerical virtual lab under ex vivo settings is reported, where FUS treatment for ex vivo porcine liver was conducted and MB augmentation effects to treatment outcome under different MB conditions were compared. It is found that the agreement between our numerical prediction and experimental measurements in the referred ex vivo study is reasonably satisfactory. Though more extensive validations are needed when extra ex vivo studies in the public domain become available, this intermediate progress illustrates the potential of this novel numerical platform serving as a virtual lab of microbubble-augmented FUS for noninvasive tumor ablation.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.